GlassScriptPhysician profile
Ashley Kopec
NPI 1336882539
$732.80
in general payments reported to CMS, 2019-2025
16 companies · $733 in 2025
The $733 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640 · Education: $92.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.81 |
| Education | $92.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $171.08 | 2025 | Jemperli, Ojjaara |
| Genentech USA, INC. | $114.03 | 2025 | Tecentriq Hybreza, Phesgo, Venclexta |
| Seagen INC. | $92.99 | 2025 | |
| Array Biopharma INC | $49.31 | 2025 | Braftovi, Mektovi, Tukysa |
| Abbvie INC. | $47.05 | 2025 | |
| Tersera Therapeutics LLC | $30.66 | 2025 | Zoladex |
| Alexion Pharmaceuticals, INC. | $29.56 | 2025 | Ultomiris |
| Merck Sharp & Dohme LLC | $27.02 | 2025 | Keytruda, Keytruda Qlex |
| Dendreon Pharmaceuticals LLC | $23.94 | 2025 | Provenge |
| Novartis Pharmaceuticals Corporation | $23.66 | 2025 | |
| Pharmacosmos Therapeutics INC. | $23.47 | 2025 | Monoferric |
| Agios Pharmaceuticals, INC. | $21.00 | 2025 | Pyrukynd |
| Bayer Healthcare Pharmaceuticals INC. | $20.56 | 2025 | |
| Pfizer INC. | $20.20 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.96 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $18.31 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Kopec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.